Nephrology Journal Club on X: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy
κ-opioid receptor - Wikipedia
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Peptide Analgesics – Opioid Peptides
κ-opioid receptor - Wikipedia
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Antagonists of the kappa opioid receptor - ScienceDirect
Kinase cascades and ligand-directed signaling at the kappa opioid receptor | Psychopharmacology
Opioid Receptor | kappa, mu Opioid Receptor
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists